on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Two Upcoming Conferences
Jaguar Health, Inc., a San Francisco-based pharmaceutical company, has announced participation in two key conferences in December 2024. Lisa Conte, the company's founder and CEO, will represent Jaguar Health. The engagements include an in-person presentation at NobleCon20 on December 3, followed by a virtual appearance at the Emerging Growth Conference on December 5. These opportunities allow Jaguar Health to showcase its efforts in developing novel gastrointestinal medications derived from rainforest plants.
The NobleCon20 presentation will take place at Florida Atlantic University's Executive Education Complex. Conference participants can access a replay of the session online after the event. Details for both conference participations are available on respective websites and platforms, allowing widespread access to Jaguar Health's initiatives and developments in the pharmaceutical landscape.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news